Kevin Schwartzman MD, MPH, FRCPC
Phone: 514-934-1934, extensions 32560/32153
Research focuses on the clinical and economic evaluation of interventions in tuberculosis and other respiratory diseases in addition to research on the local epidemiology of tuberculosis in Montreal, including spatial and geographic aspects.
tuberculosis, epidemiology, public health, quality of life, cost-effectiveness
Schwartzman K, Oxlade O, Barr RG, Grimard F, Acosta I, Baez J, Ferreira E, Melgen RE, Morose W, Cruz Salgado A, Jacquet V, Maloney S, Laserson K, Pablos-Mendez A, Menzies D. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med2005; 353:1008-20.
Wanyeki I, Olson S, Brassard P, Menzies D, Ross N, Behr M, Schwartzman K. Dwellings, crowding and tuberculosis in Montreal. Soc Sci Med2006; 63:501-511.
Haase I, Olson S, Behr MA, Wanyeki I, Thibert L, Scott A, Zwerling A, Ross N, Brassard P, Menzies D, Schwartzman K. Use of geographic and genotyping tools to characterize tuberculosis transmission in Montreal. Int J Tuberc Lung Dis 2007; 11:632-638.
Tseng CL, Oxlade O, Menzies D, Aspler A, Schwartzman K. Cost-effectiveness of novel vaccines for tuberculosis control: decision analysis. BMC Public Health 2011; 11:55.
Rossi C, Zwerling A, Thibert L, Rivest P, McIntosh F, Behr MA, Benedetti A, Menzies D, Schwartzman K. Mycobacterium tuberculosis transmission over an 11-year period in an urban, low-incidence setting. Int J Tuberc Lung Dis 2012; 16:312-318.
Bauer M, Leavens A, Schwartzman K. A systematic review and meta-analysis of the impact of tuberculosis on health-related quality of life. Quality of Life Research 2012; early on-line publication December 12, 2012 DOI: 10.1007/s11136-012-0329-x